Abstract
Early breast cancer is usually treated with a combination of surgery and radiotherapy. Standard external beam radiotherapy takes 2-6 weeks to complete. In the International randomised controlled TARGIT-A Trial, a single dose of intra-operative radiotherapy was compared to standard radiotherapy. Tammy Corica investgated cosmetic and quality of life outcomes and health professional and patient preferences as secondary endpoints of TARGIT-A. The single dose was found to be acceptable by patients and health professionals, improved treatment-related quality of life and did not adversely affect cosmetic outcome; all are important points for patients and their doctors to consider when making treatment-related decisions.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 23 May 2018 |
| DOIs | |
| Publication status | Unpublished - 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver